Novel Digital Application for Patients With Acute Leukemia

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2030

Conditions
Relapsed Adult Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
Interventions
BEHAVIORAL

DREAMLAND

Participants assigned to DREAMLAND will start using DREAMLAND during the first week of their hospitalization, with a suggested timeline of reviewing one module each week to complete the required modules by week 4 of their hospital stay.

BEHAVIORAL

VITAL WELLNESS

Participants assigned to VITAL WELLNESS will start using VITAL WELLNESS during the first week of their hospitalization, with a suggested timeline of reviewing one module each week to complete the required modules by week 4 of their hospital stay.

Trial Locations (3)

27710

NOT_YET_RECRUITING

Duke University, Durham

98109

NOT_YET_RECRUITING

Fred Hutchinson Cancer Research Center (FHCRC), Seattle

02114

RECRUITING

Massachusetts General Hospital (MGH), Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Massachusetts General Hospital

OTHER